1,8-Diazabicyclo(5.4.0)undec-7-ene → HCID 67367073, compound
Reaction equation
N12CCCN=C1CCCCC2.[F:12][C:13]([F:27])([F:26])[C:14]1[CH:19]=[CH:18][N:17]=[C:16]([C:20]2[NH:21][O:22][C:23](=[O:25])[N:24]=2)[CH:15]=1.[CH:28]([N:31]([CH:35]([CH3:37])[CH3:36])[C:32](Cl)=[O:33])([CH3:30])[CH3:29]>N1C=CC=CC=1>[F:27][C:13]([F:12])([F:26])[C:14]1[CH:19]=[CH:18][N:17]=[C:16]([C:20]2[N:24]([C:32]([N:31]([CH:35]([CH3:37])[CH3:36])[CH:28]([CH3:30])[CH3:29])=[O:33])[C:23](=[O:25])[O:22][N:21]=2)[CH:15]=1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To 1 ml of pyridine were added 0.28 g of 1,8-diazabicyclo[5,4,0]undec-7-ene, and 0.3 g of 3-(4-trifluoromethylpyridin-2-yl)-1,2,4-oxadiazol-5-one, and 0.3 g of N,N-diisopropylcarbamoyl chloride was added at room temperature. After stirring for 8 hours, the resultant solution was concentrated, and the residue was subjected to silica gel column chromatography to obtain 0.09 g of 3-(4-trifluoromethylpyridin-2-yl)-N,N-diisopropyl-1,2,4-oxadiazol-5-one-4-carboxamide (present compound (18)).
Workup
- additionwas added at room temperature
- concentrationthe resultant solution was concentrated
Sources & evidence
- ORD record
- ord-1923d867951f4e38b2d5e09ea91660f6
- Source dataset
- uspto-grants-2012_11
- Patent number
- US08318776B2
Reaction notes
Loading…